Bioceres Crop Solutions Q1 2026 Results: Revenue Down 17%, Gross Margin Up 7.5%, and Adjusted EBITDA Up 61%
ByAinvest
Wednesday, Nov 12, 2025 5:16 pm ET1min read
BIOX--
Bioceres Crop Solutions reported Q1 2026 revenues of $77.5m, a 17% decline YoY, due to the seed model transition and pruning of low-margin sales. Gross profit was $36.2m, a 3% reduction, with gross margin expanding to 47% from 40%. Operating profit was $7.1m, net loss was $7.5m, and adjusted EBITDA was $13.6m. Working capital continued to improve year over year and sequentially.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet